| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/29/1989 | US4861580 Composition using salt form of organic acid derivative of alpha-tocopheral |
| 08/24/1989 | WO1989007656A2 Clinical testing, monitoring and pharmaceutical compositions for treatment of auto-immune diseases |
| 08/24/1989 | WO1989007454A1 Pharmaceutical composition for treatment of lung obstructions |
| 08/24/1989 | WO1989007453A1 Medicinal preparations characterized by a combination of cytostatic agents, hormonal therapeutic agents and phosphone derivatives |
| 08/24/1989 | DE3804686A1 Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten Drugs with a combination of cytostatic agents or hormone therapeutics and phosphonoderivaten |
| 08/24/1989 | DE3804285A1 Adhesive wax and method for use for bleeding and inflammation of the marginal periodontium, in particular gingivitis and periodontitis |
| 08/23/1989 | EP0329185A2 Alteration of pharmacokinetics of proteins by charge modification |
| 08/23/1989 | EP0328957A2 Mixture of a thrombolytically acting and an antithrombolytically acting substance |
| 08/22/1989 | US4859685 Anesthetic composition and method of using the same |
| 08/16/1989 | EP0328389A2 Compostions for treating intracranial tumors |
| 08/16/1989 | EP0327640A1 Immunotherapeutic compositions for the treatment of acquired immune deficiency syndrome |
| 08/16/1989 | EP0327612A1 Pharmaceutical therapeutic use of glutathione derivatives |
| 08/15/1989 | US4857315 Compositions containing golgi alpha-mannosidase II inhibitors |
| 08/15/1989 | CA1258430A1 Cough/cold mixtures comprising non-steroidal anti- inflammatory drugs |
| 08/10/1989 | WO1989007114A1 Novel and improved antibodies for site specific attachment of compounds |
| 08/10/1989 | WO1989007105A1 Staurosporin derivatives |
| 08/10/1989 | WO1989006975A1 Method of reducing immunoglobulin e responses |
| 08/10/1989 | WO1989006968A1 Therapeutic use of anti-t cell immunotoxin for autoimmune diseases |
| 08/10/1989 | WO1989006967A1 Immunosupression with anti-pan t-cell immunotoxin compositions |
| 08/09/1989 | EP0327365A2 Improvements in or relating to modified haptens useful as imaging and therapeutic agents |
| 08/09/1989 | EP0327283A1 Method of reducing immunoglobulin E responses |
| 08/09/1989 | EP0327200A1 Use of 3'-azido-3'-deoxythymidine for the manufacture of a medicament for the treatment of human breast carcinoma |
| 08/09/1989 | EP0327040A2 Use of dopamine and/or dopamine agonists to prepare a medicine for the treatment of the digestive tract |
| 08/08/1989 | US4855325 Treatment of mammals suffering from damage to the central nervous system |
| 08/08/1989 | US4855306 Uses of dopamine receptor agonists |
| 08/08/1989 | US4855305 Compositions and methods of effecting contraception utilizing melatonin |
| 08/08/1989 | US4855293 Anti-inflammatory compositions comprising a systemic non-steroidal anti-inflammatory drug and a cyclopentyl ether |
| 08/02/1989 | EP0326508A1 Method of fabricating an air cooled turbine blade |
| 08/02/1989 | CN1034312A Method for preventing or treating anxiety employing ace inhibitor |
| 08/01/1989 | US4853225 Process for implanting a medicament depot |
| 07/27/1989 | WO1989006692A1 Method of treating tumor cells by inhibiting growth factor receptor function |
| 07/26/1989 | EP0324947A1 Synergistic combination of decarboxylase inhibitors and L-dopa pellets |
| 07/26/1989 | EP0324802A1 Method for the treatment of body tissues and the administration of drugs thereto |
| 07/26/1989 | CN1034134A Compound and process for use treatment retrovirus-associated adenocarcinoma |
| 07/25/1989 | US4851435 Containing anionic adjuvant with lipophilic and hydrophilic groups for increased activity |
| 07/25/1989 | US4851332 Specific to surface antigens |
| 07/18/1989 | US4849412 Methods and compositions for treating viral infections |
| 07/18/1989 | US4849228 Polymer, production and use thereof |
| 07/18/1989 | CA1257540A1 Peptide antibodies and their use in detecting oncogene products |
| 07/13/1989 | WO1989006139A1 Reduction of side effects of cancer therapy |
| 07/13/1989 | WO1989006138A1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
| 07/13/1989 | WO1989006135A1 Treatment of type 2 diabetes mellitus |
| 07/13/1989 | WO1989006132A1 Reverse transcriptase inhibitors for treating adenocarcinomas |
| 07/13/1989 | WO1989006124A1 Antiviral and antibacterial activity of fatty acids and monoglycerides |
| 07/13/1989 | DE3841955A1 Synergistic combination of decarboxylase inhibitors and L-dopa pellets |
| 07/12/1989 | EP0323745A2 Pharmaceutical preparations |
| 07/04/1989 | US4844907 Combination of narcotic and non-steroidal anti-inflammatory |
| 07/04/1989 | US4844902 Topically applicable formulations of gyrase inhibitors in combination with corticosteroids |
| 07/04/1989 | US4844893 Antitumor agents |
| 06/29/1989 | WO1989005642A1 Dextrorphan potentiator for anticonvulsant composition and method |
| 06/29/1989 | WO1989005641A1 Dextromethorphan potentiator for anticonvulsant composition and method |
| 06/29/1989 | WO1989005638A1 Emulsion for parenteral administration |
| 06/29/1989 | WO1989005582A1 Chemical splinter removal |
| 06/28/1989 | EP0321870A1 Skin penetration enhancement using free base and acid addition salt combinations of active agents |
| 06/27/1989 | US4843071 Method and composition for treating obesity, drug abuse, and narcolepsy |
| 06/27/1989 | CA1256377A1 Pharmaceutical composition containing histamine h.sub.2-receptor antagonist |
| 06/21/1989 | EP0321429A1 Emulsion for parenteral administration |
| 06/21/1989 | EP0321221A2 Method for preventing or treating anxiety employing an ace inhibitor |
| 06/21/1989 | EP0320935A2 Method of preventing or treating toxemia in pregnancy using a thromboxane A2 receptor antagonist |
| 06/20/1989 | US4840962 Mixture with antihistamine, decongestant and/or antitussive agent |
| 06/15/1989 | WO1989005149A1 Methyl cellulose pharmaceutical composition |
| 06/15/1989 | DE3741414A1 Use of calcium antagonists for the treatment of inflammations and oedemas |
| 06/13/1989 | US4839354 Acetic acid analgesics with antitussives, antihistamines, decongestants |
| 06/13/1989 | US4839179 Preparation of a composition based on a finely divided active principle of low water solubility |
| 06/13/1989 | CA1255596A1 Pharmaceutical compositions containing dihydropyridine |
| 06/13/1989 | CA1255591A1 Saccharide digestion inhibiting composition |
| 06/07/1989 | EP0319333A2 Method for the prevention of graft versus host disease |
| 06/07/1989 | EP0318488A1 Stimulation of angiogenesis and promotion of endothelialisation |
| 06/01/1989 | WO1989004671A1 Differential delivery of therapeutic agents across the blood brain barrier |
| 06/01/1989 | WO1989004660A1 5-ht3 receptor antagonists for treatment of cough and bronchoconstriction |
| 05/31/1989 | EP0318201A2 Inhibition of arterial thrombotic occlusion or thromboembolism |
| 05/24/1989 | EP0316438A1 Chemical prevention or reversal of cataract by phase separation inhibitors. |
| 05/23/1989 | US4832682 Injection method and apparatus with electrical blood absorbing stimulation |
| 05/23/1989 | CA1254514A1 Method for promoting nerve regeneration |
| 05/18/1989 | WO1989004178A1 New therapeutical use of h2-receptor-blocking compounds |
| 05/18/1989 | WO1989004172A1 Wound healing composition and method |
| 05/17/1989 | EP0316212A1 Use of nitrophenyls or anti-nitrophenyl antibodies for modification of the interaction between host-sensitive cells and a pathogenic agent |
| 05/16/1989 | US4831057 Antisnoring agent |
| 05/16/1989 | US4830854 Chemical splinter removal |
| 05/16/1989 | US4830853 Ascorbic acid, sodium ascorbate |
| 05/16/1989 | CA1254140A1 Clear micellized solutions of fat soluble essential nutrients |
| 05/16/1989 | CA1254139A1 Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer |
| 05/10/1989 | EP0315456A2 Polysaccharide-modified immunoglobulins having reduced immunogenic potential or improved pharmacokinetics |
| 05/10/1989 | EP0314863A2 Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation |
| 05/09/1989 | USRE32919 Tissue-type plasminogen activator |
| 05/09/1989 | US4829083 2-amino-2-hydroxymethyl-1,3-propanediol or homolog |
| 05/09/1989 | US4829064 Cough/cold mixtures comprising non-sedating antihistamine drugs |
| 05/09/1989 | US4827587 Method of fabricating an air cooled turbine blade |
| 05/05/1989 | WO1989003838A1 Acyl deoxyribonucleoside derivatives and uses thereof |
| 05/05/1989 | WO1989003837A1 Acylated uridine and cytidine and uses thereof |
| 05/05/1989 | WO1989003692A1 Treating premenstrual or late luteal phase syndrome |
| 05/05/1989 | WO1989003691A1 Potentiation of antihypertensive effect of ace inhibitors |
| 05/05/1989 | WO1989003690A1 Application of dinitro-trinitrophenyl and its derivatives or of anti-nitrophenyl antibodies to the modification of the interaction between the target cellules of a host and a pathogenic agent |
| 05/05/1989 | WO1989003680A1 Conjugates between a drug and a nitrophenyl group and their pharmaceutical application |
| 05/03/1989 | EP0314580A1 Use of nitrophenyl groups for stimulating the capability of incorporation of a drug into the sensitive cells of a host |
| 05/03/1989 | EP0314239A2 Tripeptide renin inhibitors with N-terminal ureido or sulfamido groups |
| 05/03/1989 | DE3836006A1 Monophosphoryllipid-a-derivate und verfahren zu deren herstellung Monophosphoryl lipid A derivatives and methods for their preparation |
| 05/02/1989 | US4826987 Pyridyl and quinoline derivatives |
| 05/02/1989 | US4826825 Foods, drugs, cosmetics, chemicals, dessication |
| 04/27/1989 | DE3835099A1 Pharmazeutische zusammensetzung Pharmaceutical composition |